Urantak Tablet (Ranitidine Hydrochloride)
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.
MFDS item code 198600661 · Notified 1986.06.12
This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (ulcers, etc.), improvement of gastric mucosal lesions, and prevention of Mendelson's syndrome
This medication is effective not only for the treatment of gastric and duodenal ulcers, but also for Zollinger-Ellison syndrome and gastroesophageal reflux disease. It is used for the prevention of postoperative ulcers and for the prevention of gastric ulcers due to NSAID use. It also helps improve gastric mucosal damage such as acute and chronic gastritis flare-ups and upper gastrointestinal bleeding. It is effective for symptoms of excessive gastric acid such as heartburn and regurgitation. Overall, it is used to protect the gastric mucosa and improve symptoms through gastric acid suppression.
Administer 150 mg per dose of ranitidine twice daily, in the morning and at bedtime, orally. Gastric and duodenal ulcers Administer 150 mg per dose of this medicine twice daily, orally, or 300 mg once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 300 mg per dose twice daily, in the morning and at bedtime. The dosage and administration are the same for concomitant use to prevent ulcers caused by nonsteroidal anti-inflammatory drug administration or the occurrence of gastric and duodenal ulcers during long-term nonsteroidal anti-inflammatory drug administration. These conditions usually heal within 4 weeks; conditions caused by nonsteroidal anti-inflammatory drug administration usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. Reflux esophagitis Administer 150 mg per dose of this medicine twice daily for 8 weeks, or 300 mg once daily at bedtime. The dose may be increased to 150 mg per dose 4 times daily in patients with severe reflux esophagitis. Zollinger-Ellison syndrome Initiate treatment with an initial dose of 150 mg per dose of this medicine 3 times daily, and increase the dose as needed. In severe cases, up to 6 g per day may be administered as directed by a physician. For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions, treatment is usually initiated with an injection; once oral administration is possible, switch to oral administration and give 150 mg per dose of this medicine twice daily. Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 150 mg of this medicine 2 hours before induction of anesthesia. It is also preferable to administer 150 mg on the night before surgery. Improvement of gastric mucosal lesions (erosions, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg per dose of this medicine once daily at bedtime. Patients with renal impairment In patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the drug; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.
For patients 12 years of age and older, administer 75 mg per dose of this medicine twice daily, orally (liquid formulation only). For patients 8 〜 18 years of age, up to 150 mg per dose (2 mg per kg of body weight) may be administered twice daily.
This drug should not be used in patients with a history of hypersensitivity to its components. It should also not be administered to patients with a history of acute porphyria, as it may induce acute porphyric attacks. Patients with impaired renal function should use this drug with caution, as it may accumulate in the body; dosage reduction or prolonged dosing intervals may be necessary. Patients with impaired liver function should also use it cautiously. Patients with a history of allergic reactions to medications, elderly patients, and those taking non-steroidal anti-inflammatory drugs should be monitored closely. This drug may mask symptoms of gastric cancer, therefore patients with gastric ulcers or those over middle age with newly occurring dyspeptic symptoms must confirm that it is not a malignant condition before administration. Patients with positive Helicobacter pylori for gastric or duodenal ulcers require eradication therapy. Rarely, allergic reactions or shock symptoms may occur during this medication; if any abnormal symptoms occur, administration should be stopped immediately and medical staff should be consulted. Routine monitoring of blood, liver, and kidney functions is required. Dizziness or drowsiness may occur, so patients should avoid driving or operating dangerous machinery when these symptoms are present. Potential interactions with other medications may occur, so patients should inform the medical staff of any concomitant medications. Pregnant or nursing women should only take this medication when the benefit of treatment outweighs the risks, as its safety has not been established. Safety in children has not been adequately verified, hence caution is required. Elderly patients may require dosage adjustment due to prolonged retention of the drug in the body from renal function decline. Although special intoxication symptoms are rare in cases of overdose, appropriate treatment such as vomiting or gastric lavage may be necessary. This medication should be kept out of the reach of children, and transferring to other containers should be avoided. Long-term use may affect eye health; therefore, regular ophthalmic examinations are recommended.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a light-blocking container. Additionally, it is best stored at room temperature between 1 degree and 30 degrees Celsius. This helps maintain the medication's efficacy.
White, round tablets with a film coating
100 tablets (10 tablets/PTP × 10), 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 336mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 112mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Youngpung Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.